Sign in
4

Changes in Ownership

Alzamend Neuro, Inc. Filed Acc 0001214659-24-005472

Options or other derivatives

  • Director bought 780,780 shares at $1,000.00 ($780,000)

From the SEC's structured data for this filing

Trades in this filing

AULT MILTON C III · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-26 Purchase : show line 1 in the form Series B Convertible Preferred Stock +780 $1,000.00 $780,000 2,000 I
2024-03-26 Purchase : show line 2 in the form Warrants +780,000 2,000,000 I
Loading xslF345X05/marketforms-65403.xml…